Search - tctmd.com

Displaying 381 - 400 of 2113

Sort: Relevancy | Date

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

News Daily News

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

May 27, 2020

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

News Daily News

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Yael L. Maxwell

May 22, 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

Procedural Deaths Fall Short as Quality Metric for Hospital Acute MI Care

News Daily News

Procedural Deaths Fall Short as Quality Metric for Hospital Acute MI Care

May 01, 2020

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

April 29, 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

News Daily News

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Yael L. Maxwell

April 22, 2020

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

SCAD Readmissions Common After Acute MI, Especially in Young Women

News Daily News

SCAD Readmissions Common After Acute MI, Especially in Young Women

April 20, 2020

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

COVID-19 Linked to 38% Drop in US STEMIs

News Daily News

COVID-19 Linked to 38% Drop in US STEMIs

April 10, 2020

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

Aspirin Okay for Up to 30 Days

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

April 03, 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

March 31, 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

News Daily News

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Michael O'Riordan

March 26, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.